“…Nevertheless, these tests are costly and cannot be broadly applied yet. In addition, artificial intelligence‐based models that can estimate classification, prognosis, and, in some cases, treatment response in melanoma are being developed (Brinker et al, 2021; Forchhammer et al, 2022; Grant et al, 2022; Johannet et al, 2021; Kulkarni et al, 2020).…”